Ceramide transfer protein and cancer

Anti-Cancer Agents in Medicinal Chemistry

Volumn 11, Issue 9, 2011, Pages 904-910

  Scheffer, Luana ^a   Raghavendra, Pralhada Rao ^a   Ma, Jingjing ^a   Acharya, Jairaj K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; Ceramide; Ceramide transfer protein; Shingolipids

Indexed keywords

CERAMIDE; CERAMIDE 1 PHOSPHATE; CERAMIDE TRANSFER PROTEIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; LIPID TRANSFER PROTEIN; PACLITAXEL; SPHINGOLIPID; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG;

APOPTOSIS; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER RESEARCH; CANCER RESISTANCE; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HUMAN; LIPID METABOLISM; METABOLIC REGULATION; NONHUMAN; OVARY CANCER; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION; STRESS; TUMOR CELL;

EID: 80054061400     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/187152011797655087     Document Type: Review

References (68)

1. Acharya, U.; Acharya, J.K., Enzymes of sphingolipid metabolism in Drosophila melanogaster. Cell Mol Life Sci, 2005, 62, (2), 128-142
2. Hannun, Y.A.; Obeid, L.M., Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol, 2008, 9, (2), 139-150
3. Sonnino, S.; Prinetti, A., Gangliosides as regulators of cell membrane organization and functions. Adv Exp Med Biol, 2010, 688, 165-184
4. Chalfant, C.E.; Spiegel, S., Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. J Cell Sci, 2005, 118, (Pt 20), 4605-4612
5. Quinn, P.J., A lipid matrix model of membrane raft structure. Progress in lipid research, 2010, 49, (4), 390-406
6. Wang, X.; Rao, R.P.; Kosakowska-Cholody, T.; Masood, M.A.; Southon, E.; Zhang, H.; Berthet, C.; Nagashim, K.; Veenstra, T.K.; Tessarollo, L.; Acharya, U.; Acharya, J.K., Mitochondrial degeneration and not apoptosis is the primary cause of embryonic lethality in ceramide transfer protein mutant mice. J Cell Biol, 2009, 184, (1), 143-158
7. Rao, R.P.; Yuan, C.; Allegood, J.C.; Rawat, S.S.; Edwards, M.B.; Wang, X.; Merrill, A.H., Jr.; Acharya, U.; Acharya, J.K., Ceramide transfer protein function is essential for normal oxidative stress response and lifespan. Proc Natl Acad Sci U S A, 2007, 104, (27), 11364-11369
8. Hojjati, M.R.; Li, Z.; Jiang, X.-C., Serine palmitoyl-CoA transferase (SPT) deficiency and sphingolipid levels in mice. Biochimica et biophysica acta, 2005, 1737, (1), 44-51
9. Riboni, L.; Giussani, P.; Viani, P., Sphingolipid transport. Advances in experimental medicine and biology, 2010, 688, 24-45
10. Breslow, D.K.; Weissman, J.S., Membranes in balance: mechanisms of sphingolipid homeostasis. Molecular cell, 2010, 40, (2), 267-279
11. Funato, K.; Riezman, H., Vesicular and nonvesicular transport of ceramide from ER to the Golgi apparatus in yeast. J Cell Biol, 2001, 155, (6), 949-959
12. Collins, R.N.; Warren, G., Sphingolipid transport in mitotic HeLa cells. J Biol Chem, 1992, 267, (34), 24906-24911
13. Kok, J.W.; Babia, T.; Klappe, K.; Egea, G.; Hoekstra, D., Ceramide transport from endoplasmic reticulum to Golgi apparatus is not vesicle-mediated. Biochem J, 1998, 333 (Pt 3), 779-786
14. Moreau, P.; Cassagne, C.; Keenan, T.W.; Morre, D.J., Ceramide excluded from cell-free vesicular lipid transfer from endoplasmic reticulum to Golgi apparatus. Evidence for lipid sorting. Biochim Biophys Acta, 1993, 1146, (1), 9-16
15. Hanada, K.; Kumagai, K.; Yasuda, S.; Miura, Y.; Kawano, M.; Fukasawa, M.; Nishijima, M., Molecular machinery for non-vesicular trafficking of ceramide. Nature, 2003, 426, (6968), 803-809
16. Oskouian, B.; Saba, J.D., Cancer treatment strategies targeting sphingolipid metabolism. Advances in experimental medicine and biology, 2010, 688, 185-205
17. Wilson, J.S.; Merrill, A.S., Teaching students to care for and about people with disabilities. Nurse Educ, 2002, 27, (2), 89-93
18. Shayman, J.A., Sphingolipids. Kidney Int, 2000, 58, (1), 11-26
19. Dickson, R.C.; Lester, R.L., Sphingolipid functions in Saccharomyces cerevisiae. Biochim Biophys Acta, 2002, 1583, (1), 13-25
20. Bieber, L.L.; O'Connor, J.D.; Sweeley, C.C., The occurrence of tetradecasphing-4-enine and hexadecasphing-4-enine as the principal sphingosines of Musca domestica larvae and adults. Biochim Biophys Acta, 1969, 187, (1), 157-159
21. Hildenbrandt, G.R.; Abraham, T.; Bieber, L.L., Metabolism of ceramide phosphorylethanolamine, phosphatidylinositol, phosphatidylserine and phosphatidylglycerol by housefly larvae. Lipids, 1971, 6, (7), 508-516
22. Sims, K.J.; Spassieva, S.D.; Voit, E.O.; Obeid, L.M., Yeast sphingolipid metabolism: clues and connections. Biochem Cell Biol, 2004, 82, (1), 45-61
23. Hanada, K., Discovery of the molecular machinery CERT for endoplasmic reticulum-to-Golgi trafficking of ceramide. Mol Cell Biochem, 2006, 286, (1-2), 23-31
24. Futerman, A.H.; Stieger, B.; Hubbard, A.L.; Pagano, R.E., Sphingomyelin synthesis in rat liver occurs predominantly at the cis and medial cisternae of the Golgi apparatus. J Biol Chem, 1990, 265, (15), 8650-8657
25. Futerman, A.H.; Pagano, R.E., Determination of the intracellular sites and topology of glucosylceramide synthesis in rat liver. Biochem J, 1991, 280 (Pt 2), 295-302
26. Jeckel, D.; Karrenbauer, A.; Burger, K.N.; van Meer, G.; Wieland, F., Glucosylceramide is synthesized at the cytosolic surface of various Golgi subfractions. J Cell Biol, 1992, 117, (2), 259-267
27. Holthuis, J.C.; van Meer, G.; Huitema, K., Lipid microdomains, lipid translocation and the organization of intracellular membrane transport (Review). Mol Membr Biol, 2003, 20, (3), 231-241
28. Rao, R.P.; Acharya, J.K., Sphingolipids and membrane biology as determined from genetic models. Prostaglandins Other Lipid Mediat, 2008, 85, (1-2), 1-16
29. Norris, J.S.; Bielawska, A.; Day, T.; El-Zawahri, A.; ElOjeimy, S.; Hannun, Y.; Holman, D.; Hyer, M.; Landon, C.; Lowe, S.; Dong, J.Y.; McKillop, J.; Norris, K.; Obeid, L.; Rubinchik, S.; Tavassoli, M.; Tomlinson, S.; Voelkel-Johnson, C.; Liu, X., Combined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status report. Cancer Gene Ther, 2006, 13, (12), 1045-1051
30. Tilly, J.L.; Kolesnick, R.N., Sphingolipids, apoptosis, cancer treatments and the ovary: investigating a crime against female fertility. Biochim Biophys Acta, 2002, 1585, (2-3), 135-138
31. Kim, W.J.; Okimoto, R.A.; Purton, L.E.; Goodwin, M.; Haserlat, S.M.; Dayyani, F.; Sweetser, D.A.; McClatchey, A.I.; Bernard, O.A.; Look, A.T.; Bell, D.W.; Scadden, D.T.; Haber, D.A., Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias. Blood, 2008, 111, (9), 4716-4722
32. Ruckhaberle, E.; Rody, A.; Engels, K.; Gaetje, R.; von Minckwitz, G.; Schiffmann, S.; Grosch, S.; Geisslinger, G.; Holtrich, U.; Karn, T.; Kaufmann, M., Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast Cancer Res Treat, 2008, 112, (1), 41-52
33. Ogretmen, B.; Hannun, Y.A., Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer, 2004, 4, (8), 604-616
34. Bonnaud, S.; Niaudet, C.; Pottier, G.; Gaugler, M.H.; Millour, J.; Barbet, J.; Sabatier, L.; Paris, F., Sphingosine-1-phosphate protects proliferating endothelial cells from ceramide-induced apoptosis but not from DNA damage-induced mitotic death. Cancer Res, 2007, 67, (4), 1803-1811
35. Chmura, S.J.; Nodzenski, E.; Kharbanda, S.; Pandey, P.; Quintans, J.; Kufe, D.W.; Weichselbaum, R.R., Down-regulation of ceramide production abrogates ionizing radiation-induced cytochrome c release and apoptosis. Mol Pharmacol, 2000, 57, (4), 792-796
36. Morales, A.; Paris, R.; Villanueva, A.; Llacuna, L.; Garcia-Ruiz, C.; Fernandez-Checa, J.C., Pharmacological inhibition or small interfering RNA targeting acid ceramidase sensitizes hepatoma cells to chemotherapy and reduces tumor growth in vivo. Oncogene, 2007, 26, (6), 905-916
37. Megha; London, E., Ceramide selectively displaces cholesterol from ordered lipid domains (rafts): implications for lipid raft structure and function. J Biol Chem, 2004, 279, (11), 9997-10004
38. Goni, F.M.; Alonso, A., Effects of ceramide and other simple sphingolipids on membrane lateral structure. Biochimica Et Biophysica Acta-Biomembranes, 2009, 1788, (1), 169-177
39. Dasgupta, U.; Bamba, T.; Chiantia, S.; Karim, P.; Tayoun, A.N.; Yonamine, I.; Rawat, S.S.; Rao, R.P.; Nagashima, K.; Fukusaki, E.; Puri, V.; Dolph, P.J.; Schwille, P.; Acharya, J.K.; Acharya, U., Ceramide kinase regulates phospholipase C and phosphatidylinositol 4, 5, bisphosphate in phototransduction. Proc Natl Acad Sci U S A, 2009, 106, (47), 20063-20068
40. Lozano, J.; Berra, E.; Municio, M.M.; Diaz-Meco, M.T.; Dominguez, I.; Sanz, L.; Moscat, J., Protein kinase C zeta isoform is critical for kappa B-dependent promoter activation by sphingomyelinase. J Biol Chem, 1994, 269, (30), 19200-19202
41. Zhang, Y.; Yao, B.; Delikat, S.; Bayoumy, S.; Lin, X.H.; Basu, S.; McGinley, M.; Chan-Hui, P.Y.; Lichenstein, H.; Kolesnick, R., Kinase suppressor of Ras is ceramide-activated protein kinase. Cell, 1997, 89, (1), 63-72
42. Basu, S.; Bayoumy, S.; Zhang, Y.; Lozano, J.; Kolesnick, R., BAD enables ceramide to signal apoptosis via Ras and Raf-1. J Biol Chem, 1998, 273, (46), 30419-30426
43. Heinrich, M.; Wickel, M.; Schneider-Brachert, W.; Sandberg, C.; Gahr, J.; Schwandner, R.; Weber, T.; Saftig, P.; Peters, C.; Brunner, J.; Kronke, M.; Schutze, S., Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J, 1999, 18, (19), 5252-5263
44. Heinrich, M.; Neumeyer, J.; Jakob, M.; Hallas, C.; Tchikov, V.; Winoto-Morbach, S.; Wickel, M.; Schneider-Brachert, W.; Trauzold, A.; Hethke, A.; Schutze, S., Cathepsin D links TNFinduced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation. Cell Death Differ, 2004, 11, (5), 550-563
45. Bourbon, N.A.; Yun, J.; Kester, M., Ceramide directly activates protein kinase C zeta to regulate a stress-activated protein kinase signaling complex. J Biol Chem, 2000, 275, (45), 35617-35623
46. Shirai, K.; Kaneshiro, T.; Wada, M.; Furuya, H.; Bielawski, J.; Hannun, Y.A.; Obeid, L.M.; Ogretmen, B.; Kawamori, T., A role of sphingosine kinase 1 in head and neck carcinogenesis. Cancer Prev Res (Phila), 2011, 4, (3), 454-462
47. Cuvillier, O., Sphingosine in apoptosis signaling. Biochim Biophys Acta, 2002, 1585, (2-3), 153-162
48. Spiegel, S.; Milstien, S., Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol, 2003, 4, (5), 397-407
49. Taha, T.A.; Mullen, T.D.; Obeid, L.M., A house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death. Biochim Biophys Acta, 2006, 1758, (12), 2027-2036
50. Milhas, D.; Clarke, C.J.; Hannun, Y.A., Sphingomyelin metabolism at the plasma membrane: implications for bioactive sphingolipids. FEBS Lett, 2009, 584, (9), 1887-1894
51. Kendler, A.; Dawson, G., Hypoxic injury to oligodendrocytes: reversible inhibition of ATP-dependent transport of ceramide from the endoplasmic reticulum to the Golgi. J Neurosci Res, 1992, 31, (2), 205-211
52. Hanada, K.; Hara, T.; Fukasawa, M.; Yamaji, A.; Umeda, M.; Nishijima, M., Mammalian cell mutants resistant to a sphingomyelindirected cytolysin. Genetic and biochemical evidence for complex formation of the LCB1 protein with the LCB2 protein for serine palmitoyltransferase. J Biol Chem, 1998, 273, (50), 33787-33794
53. Fukasawa, M.; Nishijima, M.; Hanada, K., Genetic evidence for ATP-dependent endoplasmic reticulum-to-Golgi apparatus trafficking of ceramide for sphingomyelin synthesis in Chinese hamster ovary cells. J Cell Biol, 1999, 144, (4), 673-685
54. Fukasawa, M.; Nishijima, M.; Itabe, H.; Takano, T.; Hanada, K., Reduction of sphingomyelin level without accumulation of ceramide in Chinese hamster ovary cells affects detergent-resistant membrane domains and enhances cellular cholesterol efflux to methyl-beta -cyclodextrin. J Biol Chem, 2000, 275, (44), 34028-34034
55. Funakoshi, T.; Yasuda, S.; Fukasawa, M.; Nishijima, M.; Hanada, K., Reconstitution of ATP- and cytosol-dependent transport of de novo synthesized ceramide to the site of sphingomyelin synthesis in semi-intact cells. J Biol Chem, 2000, 275, (39), 29938-29945
56. Kawano, M.; Kumagai, K.; Nishijima, M.; Hanada, K., Efficient trafficking of ceramide from the endoplasmic reticulum to the Golgi apparatus requires a VAMP-associated protein-interacting FFAT motif of CERT. J Biol Chem, 2006, 281, (40), 30279-30288
57. Saito, S.; Matsui, H.; Kawano, M.; Kumagai, K.; Tomishige, N.; Hanada, K.; Echigo, S.; Tamura, S.; Kobayashi, T., Protein phosphatase 2Cepsilon is an endoplasmic reticulum integral membrane protein that dephosphorylates the ceramide transport protein CERT to enhance its association with organelle membranes. J Biol Chem, 2008, 283, (10), 6584-6593
58. Tomishige, N.; Kumagai, K.; Kusuda, J.; Nishijima, M.; Hanada, K., Casein kinase I{gamma}2 down-regulates trafficking of ceramide in the synthesis of sphingomyelin. Mol Biol Cell, 2009, 20, (1), 348-357
59. Granero-Molto, F.; Sarmah, S.; O'Rear, L.; Spagnoli, A.; Abrahamson, D.; Saus, J.; Hudson, B.G.; Knapik, E.W., Goodpasture antigen-binding protein and its spliced variant, ceramide transfer protein, have different functions in the modulation of apoptosis during zebrafish development. J Biol Chem, 2008, 283, (29), 20495-20504
60. Slomiany, A.; Grzelinska, E.; Grabska, M.; Yamaki, K.; Tamura, S.; Kasinathan, C.; Slomiany, B.L., Intracellular processes associated with glycoprotein transport and processing. Archives of biochemistry and biophysics, 1992, 298, (1), 167-175
61. Vacaru, A.M.; Tafesse, F.G.; Ternes, P.; Kondylis, V.; Hermansson, M.; Brouwers, J.F.; Somerharju, P.; Rabouille, C.; Holthuis, J.C., Sphingomyelin synthase-related protein SMSr controls ceramide homeostasis in the ER. J Cell Biol, 2009, 185, (6), 1013-1027
62. Swanton, C.; Marani, M.; Pardo, O.; Warne, P.H.; Kelly, G.; Sahai, E.; Elustondo, F.; Chang, J.; Temple, J.; Ahmed, A.A.; Brenton, J.D.; Downward, J.; Nicke, B., Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs. Cancer Cell, 2007, 11, (6), 498-512
63. Liu, Y.Y.; Han, T.Y.; Giuliano, A.E.; Cabot, M.C., Ceramide glycosylation potentiates cellular multidrug resistance. FASEB J, 2001, 15, (3), 719-730
64. Gouaze, V.; Liu, Y.Y.; Prickett, C.S.; Yu, J.Y.; Giuliano, A.E.; Cabot, M.C., Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs. Cancer Res, 2005, 65, (9), 3861-3867
65. Juul, N.; Szallasi, Z.; Eklund, A.C.; Li, Q.; Burrell, R.A.; Gerlinger, M.; Valero, V.; Andreopoulou, E.; Esteva, F.J.; Symmans, W.F.; Desmedt, C.; Haibe-Kains, B.; Sotiriou, C.; Pusztai, L.; Swanton, C., Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triplenegative breast cancer: a retrospective analysis of five clinical trials. Lancet Oncol, 2010, 11, (4), 358-365
66. Csordas, G.; Renken, C.; Varnai, P.; Walter, L.; Weaver, D.; Buttle, K.F.; Balla, T.; Mannella, C.A.; Hajnoczky, G., Structural and functional features and significance of the physical linkage between ER and mitochondria. J Cell Biol, 2006, 174, (7), 915-921
67. Craik, A.C.; Veldhoen, R.A.; Czernick, M.; Buckland, T.W.; Kyselytzia, K.; Ghosh, S.; Lai, R.; Damaraju, S.; Underhill, D.A.; Mackey, J.R.; Goping, I.S., The BH3-only protein Bad confers breast cancer taxane sensitivity through a nonapoptotic mechanism. Oncogene, 2010, 29, (39), 5381-5391
68. Li, R.; Moudgil, T.; Ross, H.J.; Hu, H.M., Apoptosis of non-smallcell lung cancer cell lines after paclitaxel treatment involves the BH3-only proapoptotic protein Bim. Cell Death Differ, 2005, 12, (3), 292-303.